Approval · Notice of Compliance 23824 · 2020
TEPADINA: Notice of Compliance 23824
Issued June 22, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 23824
- Date
- June 22, 2020
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site for the drug substance; a manufacturing site of the drug product; a release-testing site for the drug product; and primary container closure systems for the sterile drug product.
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | Not yet assigned | — |